Physician

Carl T Henningson, M.D.

According to 2025 Medicare claims, Carl Henningson, M.D. (NPI: 1609858463) practices hematology/oncology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Ocean, NJ. This provider's primary affiliated billing organization is REGIONAL CANCER CARE ASSOCIATES LLC (NPI: 1801850243; TIN: 223141761) and primary practice location at 08753-2974.

Henningson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 920 traditional Medicare patients, billed 189,980 HCPCS/CPT codes, and received $3,680,260 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 602 prescription claims across 175 beneficiaries totaling $1,410,324 in drug costs, led by Jakafi (Ruxolitinib Phosphate). 2021 DME data shows 54 claims. Open Payments data shows 247 records totaling $39,807. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,522,062 to $3,680,260. In contrast, Part D prescription costs have moved from a higher plateau to a lower plateau, from $1,473,145 to $1,410,324. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	399	135,795	$1,522,062
2016	555	164,913	$2,274,590
2017	616	149,315	$2,284,331
2018	655	171,118	$2,478,574
2019	743	269,797	$3,800,462
2020	641	250,016	$4,394,175
2021	669	286,852	$4,365,467
2022	661	235,172	$3,438,807
2023	790	205,987	$3,885,732
2024	920	189,980	$3,680,260

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	169	1,118	$1,473,145
2016	195	1,261	$1,864,266
2017	183	1,255	$2,424,284
2018	186	1,175	$2,891,844
2019	208	1,399	$3,564,482
2020	207	1,294	$3,898,129
2021	204	915	$2,017,972
2022	178	752	$1,560,701
2023	181	710	$1,155,743
2024	175	602	$1,410,324

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	57	$40,704
2016	N/R	42	$18,171
2017	N/R	16	$4,715
2018	N/R	49	$8,661
2019	N/R	34	$3,948
2020	N/R	72	$4,347
2021	N/R	54	$2,405
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	420	1,164	$100
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	296	875	$97
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	204	536	$65
36415	Insertion of needle into vein for collection of blood sample	498	2,097	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	369	1,509	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	26	780	$450,140
Eliquis	Apixaban	53	3,868	$69,185
Xarelto	Rivaroxaban	30	1,362	$24,701
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	510	$2,543
Dexamethasone	Dexamethasone	55	956	$1,512

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	247	$39,807	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carl T. Henningson, M.D.?

Tedicare shows public-source Medicare data for Carl T. Henningson, M.D. (NPI 1609858463), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carl T. Henningson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carl T. Henningson, M.D.?

Carl T. Henningson, M.D. is linked to REGIONAL CANCER CARE ASSOCIATES LLC (billing NPI 1801850243) in the available physician profile data.

Does Carl T. Henningson, M.D. have Open Payments data?

Carl T. Henningson, M.D. has 247 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.